Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rosacea | 5 | 2007 | 13 | 0.990 |
Why?
|
| Dermatologic Agents | 4 | 2013 | 30 | 0.930 |
Why?
|
| Metronidazole | 5 | 2007 | 161 | 0.730 |
Why?
|
| Acne Vulgaris | 4 | 2009 | 26 | 0.720 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2007 | 302 | 0.560 |
Why?
|
| Dermatology | 1 | 2018 | 33 | 0.550 |
Why?
|
| Naphthalenes | 3 | 2006 | 38 | 0.490 |
Why?
|
| Diclofenac | 2 | 2007 | 6 | 0.480 |
Why?
|
| Keratosis | 2 | 2007 | 18 | 0.470 |
Why?
|
| Administration, Topical | 8 | 2013 | 132 | 0.450 |
Why?
|
| Anti-Infective Agents | 4 | 2007 | 265 | 0.440 |
Why?
|
| Pulse Therapy, Drug | 1 | 2014 | 10 | 0.430 |
Why?
|
| Skin Diseases, Infectious | 1 | 2014 | 25 | 0.420 |
Why?
|
| Disease Eradication | 1 | 2014 | 40 | 0.410 |
Why?
|
| Keratosis, Actinic | 1 | 2013 | 15 | 0.400 |
Why?
|
| Vaccines | 1 | 2018 | 383 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 504 | 0.390 |
Why?
|
| Vaccination | 1 | 2018 | 1040 | 0.380 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 721 | 0.370 |
Why?
|
| Complementary Therapies | 1 | 2012 | 44 | 0.370 |
Why?
|
| Dicarboxylic Acids | 3 | 2006 | 37 | 0.340 |
Why?
|
| Neglected Diseases | 1 | 2014 | 152 | 0.340 |
Why?
|
| Skin Diseases | 1 | 2012 | 142 | 0.340 |
Why?
|
| Armadillos | 1 | 2008 | 1 | 0.290 |
Why?
|
| Cercocebus atys | 1 | 2008 | 9 | 0.280 |
Why?
|
| Leprosy | 1 | 2008 | 16 | 0.280 |
Why?
|
| Zoonoses | 1 | 2008 | 53 | 0.280 |
Why?
|
| Eflornithine | 1 | 2007 | 15 | 0.260 |
Why?
|
| Hirsutism | 1 | 2007 | 24 | 0.260 |
Why?
|
| Hair | 1 | 2007 | 32 | 0.250 |
Why?
|
| Face | 1 | 2007 | 196 | 0.230 |
Why?
|
| Sunlight | 1 | 2004 | 27 | 0.210 |
Why?
|
| Lichen Nitidus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 567 | 0.210 |
Why?
|
| Retinoids | 2 | 2009 | 29 | 0.200 |
Why?
|
| Clindamycin | 1 | 2003 | 40 | 0.200 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 55 | 0.190 |
Why?
|
| Administration, Cutaneous | 3 | 2007 | 68 | 0.180 |
Why?
|
| Gels | 3 | 2007 | 70 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2004 | 469 | 0.160 |
Why?
|
| Adapalene | 3 | 2006 | 3 | 0.160 |
Why?
|
| Emergence Delirium | 1 | 2020 | 4 | 0.160 |
Why?
|
| Humans | 21 | 2023 | 132158 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2020 | 217 | 0.130 |
Why?
|
| Anesthesia | 1 | 2020 | 210 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2007 | 13017 | 0.120 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2014 | 5 | 0.110 |
Why?
|
| Skin Diseases, Viral | 1 | 2014 | 4 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2006 | 243 | 0.110 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2014 | 23 | 0.100 |
Why?
|
| World Health Organization | 1 | 2014 | 115 | 0.100 |
Why?
|
| Drug Therapy, Combination | 3 | 2009 | 1171 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 739 | 0.100 |
Why?
|
| Homeopathy | 1 | 2012 | 4 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2007 | 1638 | 0.100 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2012 | 2 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 3096 | 0.100 |
Why?
|
| Medicine, Ayurvedic | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hypnosis | 1 | 2012 | 11 | 0.100 |
Why?
|
| Tropical Medicine | 1 | 2014 | 104 | 0.100 |
Why?
|
| Biofeedback, Psychology | 1 | 2012 | 38 | 0.090 |
Why?
|
| Communicable Disease Control | 1 | 2014 | 141 | 0.090 |
Why?
|
| Developing Countries | 1 | 2014 | 306 | 0.090 |
Why?
|
| Male | 9 | 2023 | 65464 | 0.080 |
Why?
|
| Pediatrics | 1 | 2020 | 1243 | 0.080 |
Why?
|
| Female | 8 | 2020 | 71430 | 0.080 |
Why?
|
| PUVA Therapy | 1 | 2008 | 4 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1140 | 0.070 |
Why?
|
| Animal Experimentation | 1 | 2008 | 3 | 0.070 |
Why?
|
| Mycobacterium leprae | 1 | 2008 | 5 | 0.070 |
Why?
|
| Pemphigoid, Bullous | 1 | 2008 | 5 | 0.070 |
Why?
|
| Monkey Diseases | 1 | 2008 | 17 | 0.070 |
Why?
|
| Middle Aged | 5 | 2007 | 28939 | 0.070 |
Why?
|
| Adult | 5 | 2007 | 31755 | 0.070 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2008 | 77 | 0.070 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2008 | 100 | 0.070 |
Why?
|
| Leisure Activities | 1 | 2007 | 10 | 0.060 |
Why?
|
| Telangiectasis | 1 | 2007 | 9 | 0.060 |
Why?
|
| HIV | 1 | 2008 | 178 | 0.060 |
Why?
|
| Erythema | 1 | 2007 | 29 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2008 | 497 | 0.060 |
Why?
|
| Pruritus | 1 | 2007 | 50 | 0.060 |
Why?
|
| Safety | 1 | 2007 | 216 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 5283 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 21018 | 0.060 |
Why?
|
| Self Concept | 1 | 2007 | 163 | 0.060 |
Why?
|
| Social Behavior | 1 | 2007 | 217 | 0.060 |
Why?
|
| Tetracycline | 1 | 2005 | 75 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2009 | 1240 | 0.050 |
Why?
|
| Aged | 4 | 2008 | 21279 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 6924 | 0.050 |
Why?
|
| Forecasting | 1 | 2005 | 360 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 310 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 459 | 0.050 |
Why?
|
| Nicotinic Acids | 1 | 2002 | 8 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 693 | 0.050 |
Why?
|
| Tretinoin | 1 | 2002 | 97 | 0.040 |
Why?
|
| Skin | 1 | 2023 | 553 | 0.040 |
Why?
|
| Anesthesia Recovery Period | 1 | 2020 | 23 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1624 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2005 | 561 | 0.040 |
Why?
|
| Child | 3 | 2020 | 26383 | 0.040 |
Why?
|
| Quality of Life | 1 | 2007 | 2117 | 0.030 |
Why?
|
| HIV Infections | 1 | 2008 | 2042 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 4078 | 0.030 |
Why?
|
| Animals | 2 | 2008 | 34288 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1307 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3357 | 0.020 |
Why?
|
| United States | 1 | 2006 | 11867 | 0.020 |
Why?
|
| Keloid | 1 | 2009 | 11 | 0.020 |
Why?
|
| Phototherapy | 1 | 2009 | 37 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2009 | 196 | 0.020 |
Why?
|
| Prurigo | 1 | 2008 | 1 | 0.020 |
Why?
|
| Psoriasis | 1 | 2008 | 52 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8613 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 711 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 645 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 13355 | 0.010 |
Why?
|
| Sulfacetamide | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sulfur | 1 | 2004 | 10 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 15103 | 0.010 |
Why?
|
| Low-Level Light Therapy | 1 | 2004 | 19 | 0.010 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2004 | 69 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1690 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2567 | 0.010 |
Why?
|